


{"ok":true,"api":{"name":"SAIMSARA Evidence Object Discovery API","version":"v1"},"mode":"doc_key","editorial_verification":{"status":"human_reviewed","trust_label":"machine_generated_human_reviewed","method":"World ID proof-of-human editorial account","scope":["clinical_integrity","reference_quality","scientific_coherence"],"verification_note":"This Evidence Object is machine-generated and human-reviewed. World ID is used to verify that editorial oversight was submitted by a unique human account.","does_not_mean":"World ID verifies proof-of-human editorial oversight; it does not independently certify the scientific truth of every claim."},"object":{"object_type":"saimsara_evidence_object_metadata","doc_key":"vascular::THIN_CAP_FIBROATHEROMA_PM","issue_slug":"vascular","doc_id":"THIN_CAP_FIBROATHEROMA_PM","title":"Thin-Cap Fibroatheroma and Major Adverse Cardiovascular Events","doi":"10.62487/saimsara74e16474","doi_url":"https://doi.org/10.62487/saimsara74e16474","version":"2026-06-03","source_name":"PubMed","article_url":"https://saimsara.com/sessions/thin-cap-fibroatheroma-20260603-154358-74e16474/","image_url":"","topic_tags":"thin-cap fibroatheroma,optical coherence tomography,plaque vulnerability,fibrous cap thickness,lipid-rich plaque,intravascular imaging,major adverse cardiac events,coronary artery disease,fractional flow reserve,percutaneous coronary intervention","keywords":["thin-cap fibroatheroma","optical coherence tomography","plaque vulnerability","fibrous cap thickness","lipid-rich plaque","intravascular imaging","major adverse cardiac events","coronary artery disease","fractional flow reserve","percutaneous coronary intervention"],"metrics":{"included_all":520,"included_original":457,"reference_index":225,"total_participants":112158},"discover_url":"https://saimsara.com/api/v1/discover.php?doc_key=vascular%3A%3ATHIN_CAP_FIBROATHEROMA_PM","paid_evidence_url":"https://saimsara.com/api/v1/evidence.php?doc_key=vascular%3A%3ATHIN_CAP_FIBROATHEROMA_PM","price":{"amount":"5.00","currency":"USD","units":5,"unit_amount":"1.00"},"payment_methods":["api_key","stripe_checkout","object_grant","x402"],"text_length":27453,"preview":"Results Key finding aligned to the query: The dominant and most consistently replicated signal across the evidence base is that OCT-defined TCFA serves as an independent, robust predictor of future major adverse cardiovascular events (MACE), particularly non-culprit lesion-related MI and cardiac death, across a spectrum of clinical presentations including ACS, stable coronary artery disease (CAD), and diabetes mellitus. This prognostic value persists even in angiographically non-obstructive, fractional flow reserve (FFR)-negative lesions, underscoring that plaque vulnerability rather than stenosis severity drives events. In diabetes patients with FFR-negative lesions, TCFA presence conferred…","trust_label":"machine_generated_human_reviewed","editorial_verification":{"status":"human_reviewed","trust_label":"machine_generated_human_reviewed","method":"World ID proof-of-human editorial account","scope":["clinical_integrity","reference_quality","scientific_coherence"],"verification_note":"This Evidence Object is machine-generated and human-reviewed. World ID is used to verify that editorial oversight was submitted by a unique human account.","does_not_mean":"World ID verifies proof-of-human editorial oversight; it does not independently certify the scientific truth of every claim."},"checkout":{"method":"POST","url":"https://saimsara.com/create_checkout_session.php","content_type":"application/x-www-form-urlencoded","params":{"plan":"evidence_object","doc_key":"vascular::THIN_CAP_FIBROATHEROMA_PM"},"optional_params":{"customer_email":"user@example.com"},"price":{"amount":"5.00","currency":"USD","units":5,"unit_amount":"1.00"},"curl_example":"curl -X POST https://saimsara.com/create_checkout_session.php -d \"plan=evidence_object\" -d \"doc_key=vascular::THIN_CAP_FIBROATHEROMA_PM\" -d \"customer_email=user@example.com\""},"access_after_payment":{"header":"X-SAIMSARA-Payment-Proof","endpoint":"https://saimsara.com/api/v1/evidence.php?doc_key=vascular%3A%3ATHIN_CAP_FIBROATHEROMA_PM","curl_example":"curl -H \"X-SAIMSARA-Payment-Proof: YOUR_PAYMENT_PROOF_TOKEN\" \"https://saimsara.com/api/v1/evidence.php?doc_key=vascular%3A%3ATHIN_CAP_FIBROATHEROMA_PM\""}}}